Asset
Nitric Oxide
Revenue
No revenue reported in loaded filings.
Clinical trials (5)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT04060979 | phase2 | completed | 2019-11-06 | 2020-03-02 | Beyond Air Inc. | Evaluation of Two Doses of Nitric Oxide (NO) Given Intermittently Via Inhalation to Subjects With Bronchiolitis |
| NCT03053388 | phase3 | completed | 2017-03-05 | 2018-04-28 | Beyond Air Inc. | Evaluation of the Efficacy Safety and Tolerability of Nitric Oxide Given Intermittently Via Inhalation to Subjects With Bronchiolitis |
| NCT01958944 | phase1_2 | completed | 2013-12-01 | 2015-11-01 | Beyond Air Inc. | Evaluation of the Safety and Tolerability of Inhaled Nitric Oxide to Subjects With Cystic Fibrosis |
| NCT01768884 | phase1_2 | completed | 2013-01-01 | 2016-01-01 | Beyond Air Inc. | Evaluation of the Safety and Tolerability of Nitric Oxide (NO) Via Inhalation to Subjects With Bronchiolitis |
| NCT03208764 | phase2 | completed | 2017-07-24 | 2018-05-01 | Beyond Air Inc. | Inhaled Nitric Oxide for Patients With MABSC |
FDA applications (0)
This company has no applications containing this asset.